Ken Morrison

Global Head Operational Strategy & Planning Oncology @Fortrea

Maidenhead, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2023 — Present

Global Head Operational Strategy & Planning Oncology @Fortrea

View department →

Edinburgh, GB

An Highly Experienced global leader in clinical drug development, supporting clients Internationally in bringing their assets into the clinic for the first time, through to achieving registration and life cycle management. Leveraging R&D expertise in leading a cross functional team, ensures strategic planning and efficient operational clinical delivery of complex assets from ATMPs to Biosimilars focused in Immune and Oncology indications to ensure fast decision making and optimal timeline to market. As a key leader in the space, publishes and speaks to areas of innovation from data solutions to technology application in drug development.

EDUCATION

1994 — 1997

Harvard Medical School

Postdoc, Pharmacology

1987 — 1991

University of Strathclyde

BSc (Joint Honours) Biochemistry and Pharmacology

1996 — 1997

Harvard University

Diploma in Ethical Conduct of Preclinical & Clunical Research, Preclinical and clinical research

1991 — 1994

University of Aberdeen

PhD, Pharmacology

1995 — 1997

Boston University

Diploma, Regulatory and Clinical Pathways in Drug Development

ABOUT KEN MORRISON

Current role monitors global service implementation of oncology focused services for Covance business including investment into existing and new services.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Ken Morrison — Global Head Operational Strategy & Planning Oncology at Fortrea in Maidenhead, GB | Unifers